Clinical Trials
31 trialsNCT04943380 2026-04-24
DRIVE
Pacific Edge Limited
Completed
NCT05889195 2026-04-24
microDRIVE
Pacific Edge Limited
Recruiting
NCT04822350 2026-04-02
AVENANCE
Pfizer
Completed
NCT06412848 2026-02-24
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Active not recruiting
NCT07386847 2026-02-04
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer
Not yet recruiting
NCT03782207 2026-01-08
IMreal
Hoffmann-La Roche
Active not recruiting
NCT06870253 2026-01-06
Evaluating Bladder CAREâ„¢, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Pangea Laboratory LLC
Active not recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT03374267 2025-09-22
CARAT
iOMEDICO AG
Recruiting
NCT05902494 2025-07-20
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Seagen Inc.
Completed
NCT06421311 2025-06-05
URADJ
Bristol-Myers Squibb
Terminated
NCT05945108 2025-04-11
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
AstraZeneca
Completed
NCT06912672 2025-04-08
UMT-UC
Shanghai Epiprobe Biotechnology Co., Ltd.
Not yet recruiting
NCT05431777 2025-04-01
A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT04510129 2025-03-12
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
Recruiting
NCT05874921 2025-02-28
uTRACT
UroGen Pharma Ltd.
Recruiting
NCT05337189 2025-02-13
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Recruiting
NCT06564363 2024-08-21
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Wuhan Ammunition Life-tech Co., Ltd
Unknown
NCT05699135 2024-04-24
TRAVELER
Pfizer
Terminated
NCT03788746 2024-02-22
PREVAIL
AstraZeneca
Completed
NCT04106167 2023-09-21
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Terminated
NCT04314245 2023-05-24
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
AnchorDx Medical Co., Ltd.
Completed
NCT03330886 2023-03-13
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
Hoffmann-La Roche
Completed
NCT05052372 2022-12-22
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
xCures
Terminated
NCT03232593 2022-08-24
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Hoffmann-La Roche
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03794128 2020-09-11
A Study of Personalized Neoantigen Cancer Vaccines
Gritstone bio, Inc.
Completed
NCT02700659 2020-03-04
The Cxbladder Monitoring Study
Pacific Edge Limited
Completed
NCT03399643 2019-04-19
Announce
Hoffmann-La Roche
Terminated
NCT01103544 2015-05-13
JONAS-1
Pierre Fabre Pharma GmbH
Completed
NCT01551342 2014-03-21
Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology
Zetiq Technologies
Unknown